Treatment-emergent adverse events (TEAEs) occurred in a similar proportion of patients in each group, and were mostly mild or ...

Organon has shared positive results from a long-term extension (LTE) study of its Vtama (tapinarof) cream, 1% in atopic ...

The reduction in itch was the greatest contributor to quality-of-life improvement for adolescents and adults with atopic ...

Shawn Kwatra, MD, FAAD, physician scientist at the University of Maryland Medical System, presented data at the American Academy of Dermatology 2025 annual conference on the rapid efficacy of topical ...

In September 2024, a readout from a separate trial of rocatinlimab elicited mixed reactions from analysts, who found the ...

The three-year study of Ebglyss saw an additional 83% of dermatitis patients achieving ‘almost clear’ skin using the single ...

DURHAM, N.C. & CAMBRIDGE, Mass. & SEOUL, South Korea, March 10, 2025--Hudson Therapeutics, the U.S. subsidiary of Shaperon, ...

Researchers have identified in a new study that sodium-glucose cotransporter-2 inhibitors (SGLT2i) could diminish the risk ...

The FDA approved omalizumab-igec (Omlyclo) as the first biosimilar for omalizumab (Xolair) and the first for any respiratory ...

Vitamin B6 deficiency may cause symptoms such as dermatitis and neuropathy in different parts of the body. Learn how to tell if your levels of it are low.

Incyte's Phase 3 TRuE-PN trials show ruxolitinib cream improves itch relief in prurigo nodularis, though TRuE-PN2's primary ...

Relief from itching and swelling - Stay comfortable and enjoy the outdoors with our expert recommendations for dealing with ...